OncLive

Most Recent

Systemic Therapies Improve Breast Cancer With Brain Metastases Management

July 7th 2020

By Jessica Hergert

Kamran A. Ahmed, MD, discusses the evolution of treatment for patients with breast cancer brain metastases, recent pivotal findings that have significantly improved survival for these patients, and a number of agents on the horizon.

Yale Cancer Center Researchers Awarded $2.8 Million Cancer Systems Immunology Grant

July 7th 2020

Yale Cancer Center researchers were awarded a $2.8 million grant from the National Cancer Institute to evaluate and model cytokine signaling related to immunotherapy for cancer.

FDA Approves Oral Decitabine Plus Cedazuridine For MDS

July 7th 2020

By Kristi Rosa

The FDA has approved an oral combination comprised of decitabine and cedazuridine for the treatment of select adult patients with myelodysplastic syndromes.

Beyond Cancer Type: New Pan-Tumor Targets Emerge

July 7th 2020

By Rachel Narozniak, MA

The growing use of genomic profiling technologies will help promote the development of anticancer therapies based on molecular features of a tumor rather than the body site of origin.

FDA Issues Clinical Hold on MELANI-01 Trial With UCARTCS1A in Myeloma

July 7th 2020

By Kristi Rosa

The FDA has issued a clinical hold on the phase 1 MELANI-01 trial evaluating the CAR T-cell product UCARTCS1A in the treatment of patient with relapsed/refractory multiple myeloma.

Latest Videos

All Content

x